Sumitomo Chemical India
Market cap ₹16,684 Cr
- P/E
- 29.84
- Day range
- ₹330.50 – ₹341.70
- 52-week range
- ₹310.85 – ₹572.05
- Volume
- 2.53 L
- Open
- ₹340.00
- Prev close
- ₹342.40
Latest results · Q2 FY27(consolidated)Revenue ₹907 Cr-2.4%Profit ₹157 Cr-11.5%Margin 17.3%YoY vs the same quarter last year
No red flags in exchange filings: no rising pledge, promoter selling, surveillance or critical filing on record.
SUMICHEM in NSE indices and F&O
Research profile
Composite 42 / 100Factor percentiles
Derived metrics
- Earn. yield
- 3.4%
- Graham no.
- ₹134.08
- vs Graham
- -59.9%
- ROE ÷ P/B
- 3.7%
- 12-1 mom.
- -14.4%
- Return / vol
- -0.82
- Magic Formula
- #176
- Piotroski
- 3/6
- FCF yield
- 2.3%
Appears in 10 scans
Percentiles rank this stock against the other tracked stocks and change as they do. Scans describe where figures sit today. Hover a label for its definition. Not investment advice.
Peer comparison
All 44 in Chemicals| Company | M-cap | P/E | P/B | ROE | ROCE | OPM | D/E | Sales YoY |
|---|---|---|---|---|---|---|---|---|
| Solar IndustriesSOLARINDS | ₹1.68 L Cr | 74.04 | 22.19 | 32.5% | 38.0% | 29.0% | 0.23 | +69.0% |
| Pidilite IndustriesPIDILITIND | ₹1.56 L Cr | 58.12 | 14.05 | 24.0% | 31.0% | 20.0% | 0.03 | +20.9% |
| SRF LtdSRF | ₹72,471 Cr | 31.75 | 4.80 | 13.8% | 15.0% | 19.0% | 0.35 | +34.7% |
| Linde IndiaLINDEINDIA | ₹58,548 Cr | 118.46 | 13.42 | 13.6% | 18.0% | 32.0% | 0.23 | +12.3% |
| Coromandel InternationalCOROMANDEL | ₹57,701 Cr | 37.01 | 4.30 | 16.1% | 22.0% | 9.0% | 0.12 | +6.6% |
| Gujarat FluorochemicalsFLUOROCHEM | ₹52,952 Cr | 78.39 | 6.17 | 7.6% | 10.0% | 27.0% | 0.28 | +45.5% |
| Navin Fluorine InternationalNAVINFLUOR | ₹52,759 Cr | 57.95 | 11.37 | 20.1% | 21.0% | 34.0% | 0.28 | +57.1% |
| Sumitomo Chemical IndiaSUMICHEM | ₹16,684 Cr | 29.84 | 4.62 | 17.3% | 22.0% | 20.0% | 0.02 | -2.5% |
| Sector median | ₹13,505 Cr | 31.75 | 2.86 | 9.9% | 12.0% | 15.7% | 0.27 | +21.5% |
Sector as classified in the tracked universe; medians use every tracked Chemicals company, and P/E only profitable ones. Tinted figures beat the median.
Latest news
Updated 20h agoHeadlines about Sumitomo Chemical India from the last two weeks in the financial press. Stories belong to their publishers; Rajat Finance does not endorse them.
Key metrics
- P/E (TTM)
- 31.0
- Price / Book
- 4.51
- ROE (FY26)
- 17.3%
- ROCE (latest year)
- 22%
- Dividend yield
- 0.38%
Moving averages (NSE)
- 20-day
- ₹341.23
- Price below
- 50-day
- ₹401.21
- Price below
- 200-day
- ₹444.14
- Price below
Charts & trends
From company filings. Amounts in ₹ crore.
Revenue, profit & margin - quarterly
₹ crore; a loss shows red. Operating margin below, same periods.
- Revenue
- Net profit
Operating margin
Who owns the company
% of equity by quarter, latest Sept 2026
- Promoter
- Public
- DII
- FII
Cash flows
Where cash came from and went, by fiscal year (₹ crore)
- Operating
- Investing
- Financing
- Free cash flow
Return on equity
Net profit over shareholders' equity, by fiscal year
Equity vs debt
Shareholders' equity against borrowings (₹ crore); the ratio below, same years.
- Equity
- Debt
Debt to equity
Dividends per share
₹ by fiscal year of the ex-date; the latest year runs to date.
Financial statements
| Line item | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 542 | 674 | 839 | 988 | 642 | 679 | 1,057 | 930 | 568 | 684 | 1,063 | 907 |
| YoY Sales growth | -28 | — | — | — | — | — | — | -6 | -12 | — | — | -2 |
| Expenses | 476 | 534 | 678 | 743 | 536 | 560 | 838 | 712 | 468 | 550 | 830 | 722 |
| Operating Profit | 66 | 140 | 161 | 245 | 106 | 120 | 219 | 218 | 99 | 134 | 233 | 186 |
| OPM % | 12% | 21% | 19% | 25% | 17% | 18% | 21% | 23% | 18% | 20% | 22% | 20% |
| Other Income | 27 | 27 | 26 | 31 | 31 | 32 | 39 | 39 | 21 | 32 | 74 | 44 |
| Interest | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Depreciation | 16 | 17 | 15 | 16 | 19 | 16 | 16 | 17 | 17 | 17 | 17 | 17 |
| Profit before tax | 75 | 149 | 171 | 260 | 117 | 133 | 241 | 238 | 102 | 148 | 288 | 210 |
| Tax % | 27% | 26% | 26% | 26% | 25% | 25% | 26% | 25% | 25% | 25% | 26% | 25% |
| Net Profit | 55 | 110 | 127 | 193 | 87 | 100 | 178 | 178 | 76 | 111 | 215 | 157 |
| EPS in Rs | ₹1.10 | ₹2.20 | ₹2.54 | ₹3.85 | ₹1.74 | ₹2.00 | ₹3.57 | ₹3.56 | ₹1.52 | ₹2.23 | ₹4.30 | ₹3.15 |
From company filings, updated 18 Nov 2026. Consolidated figures where the company reports them. Information only, not investment advice.
Working-capital cycle
-34 days since Mar 2021
-19 days since Mar 2021
-59 days since Mar 2021
+6 days since Mar 2021
+59 days since Mar 2021
Strengths, risks & growth
Sumitomo Chemical India Ltd. (SCIL) is one of the leading players in the industry which has a balanced portfolio of technical as well as formulation products along with backward integration for some products. The Company is known for domestic marketing of proprietary products of its Japanese parent -Sumitomo Chemical Company Limited in agrochemicals, animal nutrition, and environmental health business segments. With the integration of Excel Crop Care Limited, the Company now has a strong portfolio of generics in addition to specialty products and a strong combined marketing network. With this integration, the Company has moved up several notches in the pecking order of the Indian crop protection industry. SCIL has also marked its presence in Africa and several other geographies of the world. [1] [2]
Strengths
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 34.5%
Risks
- The company has delivered a poor sales growth of 4.13% over past five years.
Compounded Sales Growth
- 10 Years
- —
- 5 Years
- +4%
- 3 Years
- -3%
- TTM
- -3%
Compounded Profit Growth
- 10 Years
- —
- 5 Years
- +8%
- 3 Years
- +2%
- TTM
- +2%
Stock Price CAGR
- 10 Years
- —
- 5 Years
- -2%
- 3 Years
- -4%
- 1 Year
- -26%
Return on Equity
- 10 Years
- —
- 5 Years
- +19%
- 3 Years
- +16%
- Last Year
- +16%
Strengths and risks are a machine-generated checklist, not advice; growth is compounded annually over each period.
Shareholding pattern
| Holder | Dec 2025 | Mar 2026 | Jun 2026 | Sept 2026 | Change |
|---|---|---|---|---|---|
| Promoter | 75.00% | 75.00% | 75.00% | 75.00% | 0.00 pp |
| FII | 3.37% | 3.41% | 3.02% | 2.89% | -0.13 pp |
| DII | 8.65% | 8.98% | 9.33% | 9.68% | +0.35 pp |
| Public | 12.97% | 12.60% | 12.65% | 12.42% | -0.23 pp |
Filed with NSE for Sept 2026: promoters 75.00%, public 25.00%
Analysts & fund holdings
Who holds the shares, quarter by quarter
Mutual funds 7.68% (+0.41 pp)- Promoters75.0%
- Foreign institutions2.9%
- Mutual funds7.7%
- Insurance0.8%
- Other domestic institutions1.2%
- Retail6.2%
- Others6.3%
| Fund | % of company | % of fund | 3-month change |
|---|---|---|---|
| Aditya Birla SL Flexi Cap Fund | 0.87% | 0.53% | -0.29 pp |
| Nippon India Small Cap Fund | 0.84% | 0.19% | -0.04 pp |
| HSBC Small Cap Fund | 0.83% | 0.82% | -0.52 pp |
| Aditya Birla SL ELSS Tax Saver Fund | 0.68% | 0.86% | -0.22 pp |
| Edelweiss Mid Cap Fund | 0.58% | 0.53% | -0.31 pp |
Scorecard
- Performance
- Low
- Valuation
- High
- Growth
- Low
- Profitability
- High
- Entry point
- Good
- Red flags
- Low
Analyst coverage, holdings and scorecard from market data; not a recommendation by Rajat Finance.
Risk & trend
From 292 daily sessions to 18 Nov 2026.
Risk
- Volatility (1Y)
- 35.6%
- Downside volatility
- 32.5%
- Worst 5% of days
- 3.6%
- Average of that tail
- 4.3%
- Max drawdown (1Y)
- 47.8%
- Below its peak
- 44.5%
Against the market
- Beta vs Nifty 50
- 1.10
- Correlation
- 0.42
- Relative strength (3M)
- -44.2%
- ATR (14)
- 4.1%
Return
- Return 1M
- -17.4%
- Return 3M
- -40.3%
- Return 6M
- -25.7%
- Return 1Y
- -29.3%
- vs 200-day average
- -24.7%
Momentum
- RSI (14)
- 34.9
- MACD histogram
- 5.12
- Stochastic %K
- 44.6
- ADX (14)
- 40.9
- +DI / −DI
- 17.7 / 31.4
- Money flow index
- 47.7
Participation
- Delivery (20d avg)
- 50.7%
- vs its 60-day baseline
- -0.1 pts
- Volume vs 20-day
- -0.8σ
- Close vs day's VWAP
- -0.1%
- 52-week position
- 7 / 100
These describe what this stock's price has already done. They are not forecasts, signals or recommendations, and a dash means the figure was withheld for want of enough history rather than being zero.
Financial quality
From consolidated statements to 30 Sept 2026.
Piotroski F-Score
3 of 6 tested
- Return on assets positive — passed
- Operating cash flow positive — not testableno cash flow statement for this period
- Return on assets improving — failed
- Cash flow exceeds profit — not testableneeds cash flow and profit against assets
- Debt to assets falling — failed
- Current ratio improving — passed
- No new equity issued — not testableno share count is collected, and financing cash flow mixes equity with debt
- Operating margin improving — passed
- Asset turnover improving — failed
- Free cash flow
- ₹401 Cr
- FCF yield
- 2.3%
- Cash conversion
- 0.82
- Accruals ratio
- 0.022
- Net debt
- ₹4 Cr
- Net debt / equity
- 0.00
- EV / sales
- 5.30
- Capex intensity
- 1.4%
- Revenue CAGR
- 21.2%
- Profit CAGR
- 35.5%
Computed from filed statements, not filed themselves. A dash means an input was absent, and the score counts only the criteria that could actually be tested.
Corporate actions
- dividend₹1.30
Dividend - Rs 1.30 Per Share
17 Jul 2026ex-date - dividend₹1.20
Dividend - Rs 1.20 Per Share
25 Jul 2025ex-date - dividendNot available — not reported in this filing
Dividend - Re 0.90 Per Share
19 Jul 2024ex-date - dividend₹5.00
Special Interim Dividend - Rs 5 Per Share
14 Feb 2024ex-date - dividend₹1.20
Dividend - Rs 1.20 Per Share
21 Jul 2023ex-date - dividendNot available — not reported in this filing
Dividend - Re 1 Per Sh
21 Jul 2022ex-date - dividend₹0.80
Dividend - Rs 0.80 Per Share
22 Jul 2021ex-date - dividend₹0.55
Annual General Meeting/Dividend - Rs 0.55 Per Share
2 Sept 2020ex-date
Company announcements
Written Transcript of Earnings Call held on 27th October, 2026.
Audio Recording of Earnings Call held on 27th October, 2026.
Investor Presentation for the quarter and half year ended 30th September 2026
Unaudited Financial Results for the quarter and half year ended 30.09.2026
Unaudited Financial Results (Standalone and Consolidated) for the quarter and half-year ended 30th September, 2026.
Intimation of Earnings Call with Investors and Analysts on Tuesday, 27th October, 2026
Intimation of Earnings Call with Investors and Analysts on Tuesday, 27th October, 2026
Certificate Under Regulation 74(5) of SEBI( Depositories Participants) Regulations, 2015
Sumitomo Chemical India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/10/2026 ,inter alia, to consider and approve Intimation of schedule ....
Intimation of Schedule of Institutional Investors/Analyst meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015
Intimation of Schedule of Institutional Investors and Analysts meeting to be held on Wednesday, 19th August, 2026
Compliance under Regulation 44(3) of the SEBI (LODR) Regulations, 2015.
Investor Presentation on the financial results of the Company for the quarter ended 30th June, 2026
Proceedings of 26th Annual General Meeting.
Integrated Filing (Financial) for the quarter ended 30th June, 2026.
Filed with BSE (scrip 542920); the last 45 days. Documents open at bseindia.com.
Documents
Annual reports
Earnings calls
- Oct 2026TranscriptSlidesRecording
- Jul 2026Slides
- Jun 2026TranscriptSlides
- Jan 2026Slides
- Jan 2026Slides
- Nov 2025TranscriptSlidesRecording
Credit ratings
- Rating update · 29 Apr from crisil
- Rating update · 30 Jan 2025 from crisil
- Rating update · 24 Nov 2023 from crisil
- Rating update · 29 May 2023 from crisil
- Rating update · 3 Mar 2022 from crisil
- Rating update · 25 Feb 2021 from crisil
Documents open at BSE or the rating agency that issued them.
Sourced from the company's NSE XBRL filing dated 26 Oct 2026 (unaudited). View the source filing. Figures are as filed and are not investment advice.
Sumitomo Chemical India: common questions
Answered from the figures on this page.